This inventor holds 1 USPTO granted patent. Top assignee: Crinetics Pharmaceuticals, Inc.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Samer Kahwaji: Innovator in Pharmaceutical Modulation
Introduction
Samer Kahwaji is a notable inventor based in Halifax, Canada. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of somatostatin modulators. His work is essential for advancing treatments for various diseases.
Latest Patents
Samer holds a patent for "Crystalline forms of a somatostatin modulator." This patent describes crystalline forms of 4-[(3S)-3-aminopyrrolidin-1-yl]-6-cyano-5-(3,5-difluorophenyl)-N-[(2S)-1,1,1-trifluoropropan-2-yl]pyridine-3-carboxamide. The patent outlines the uses of these crystalline forms in the preparation of pharmaceutical compositions aimed at treating diseases or conditions that would benefit from administration with a somatostatin modulator compound. He has 1 patent to his name.
Career Highlights
Samer is currently employed at Crinetics Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on developing new therapeutic options that can improve patient outcomes.
Collaborations
Samer collaborates with talented individuals such as Yuxin Zhao and Jayachandra P Reddy. Their combined expertise enhances the research and development efforts at Crinetics Pharmaceuticals.
Conclusion
Samer Kahwaji is a dedicated inventor whose work in pharmaceutical modulation is paving the way for new treatments. His contributions are vital for the advancement of medical science and patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile